EUVIMEDEUVIMED entdecken
Crossref

Heparin Derivatives and Semisynthetic Biotechnological Heparins as Angiogenesis Inhibitors

Marco Presta, Daria Leali, Helena Stabile, Roberto Ronca, Maura Camozzi, Emanuela Moroni, Stefania Nicoli, Sandra Liekens, Marco Rusnati

Frontiers in Medicinal Chemistry - Online · 01.01.2005 · 2 (1) · 371-391

DOI: 10.2174/1567204052931087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicinal Chemistry - Online, erschienen am 01.01.2005. Verfasst von Marco Presta und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis is the process of generating new capillary blood vessels. Uncontrolled endothelial cell proliferation is observed in tumor neovascularization and in angioproliferative diseases. Tumors cannot grow as a mass above few mm unless a new blood supply is induced. It derives that the control of the neovascularization process may affect tumor growth and may represent a novel approach to tumor therapy. Angiogenesis is controlled by a balance between proangiogenic and antiangiogenic factors. The angiogenic switch represents the net result of the activity of angiogenic stimulators and inhibitors, suggesting that counteracting even a single major angiogenic factor could shift the balance towards inhibition. Heparan sulfate proteoglycans are involved in the modulation of the neovascularization that takes place in different physiological and pathological conditions. This modulation occurs through the interaction with angiogenic growth factors or with negative regulators of angiogenesis. Thus, the study of the biochemical bases of this interaction may help to design glycosaminoglycan analogs endowed with angiostatic properties. The purpose of this review is to provide an overview of the structure/function of heparan sulfate proteoglycans in endothelial cells and to summarize the angiostatic properties of synthetic heparin-like compounds, chemically modified heparins, and biotechnological heparins.

Zitieren

APA

Presta, M., Leali, D., Stabile, H., Ronca, R., Camozzi, M., Moroni, E., Nicoli, S., Liekens, S., & Rusnati, M. (2005). Heparin Derivatives and Semisynthetic Biotechnological Heparins as Angiogenesis Inhibitors. Frontiers in Medicinal Chemistry - Online, 2(1), 371-391. https://doi.org/10.2174/1567204052931087

Vancouver

Presta M, Leali D, Stabile H, Ronca R, Camozzi M, Moroni E, et al. Heparin Derivatives and Semisynthetic Biotechnological Heparins as Angiogenesis Inhibitors. Frontiers in Medicinal Chemistry - Online. 2005;2(1):371-391. doi:10.2174/1567204052931087

BibTeX
@article{Presta2005,
  author = {Presta, Marco and Leali, Daria and Stabile, Helena and Ronca, Roberto and Camozzi, Maura and Moroni, Emanuela and Nicoli, Stefania and Liekens, Sandra and Rusnati, Marco},
  title = {Heparin Derivatives and Semisynthetic Biotechnological Heparins as Angiogenesis Inhibitors},
  journal = {Frontiers in Medicinal Chemistry - Online},
  year = {2005},
  volume = {2},
  number = {1},
  pages = {371--391},
  doi = {10.2174/1567204052931087}
}
Kostenlos starten →